Pomerantz LLP is investigating claims on behalf of investors ofThe Boeing Company(“Boeing” or the “Company”)(NYSE: BA). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Boeing and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information […]

Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc.(“DoubleVerify” or the “Company”)(NYSE: DV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Coinbase and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd.(“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. (“Broadmark” or the “Company”)(NYSE: BRMK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of

Pomerantz LLP announces that a class action lawsuit has been filed againstReckitt Benckiser Group Plc(“Reckitt” or the “Company”)(OTCMKTS: RBGLY).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor646-581-9980,(or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The class action

Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor646-581-9980,(or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg

Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc.(“Tempus” or the “Company”)(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. ("Dyne" or "the Company") (NASDAQ:DYN). Investors who purchased Dyne securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DYN.

Pomerantz LLP announces that a class action lawsuit has been filed againstRocketPharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg